Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor Site-Specific DNA Damage (None)
- Target
- None
- Molecular classification
- DNA, DNA Damage Response Pathway, Homologous Recombination, Non-homologous End Joining, Mismatch Repair, Translesion Synthesis Polymerases, Kinase (ATM, DNA-PK)
01
Overview
Tumor site-specific DNA damage refers to the targeted induction or exploitation of DNA lesions within tumor cells, leveraging their unique vulnerabilities in DNA repair pathways. This concept is central to many cancer therapies that aim to selectively kill cancer cells by overwhelming their compromised ability to repair genetic damage, while sparing normal tissues.
02
Mechanism of action
Induction of DNA lesions (strand breaks, crosslinks); inhibition of DNA repair pathways; exploitation of synthetic lethality
03
Biological functions
DNA repairGenome stabilityCell cycle checkpointApoptosisDNA replication
04
Disease associations
CancerDrug resistance
05
Safety considerations
Off-target toxicity to normal cellsAcquired drug resistanceSecondary malignanciesMyelosuppression
06
Interacting drugs
Etoposide
5 more in the full profile.
07
Biomarkers
BRCA1/2 mutation statusMSH2/MLH1 mutation statusMicrosatellite instability (MSI)ATM expression/activityDNA-PK expression/activity
Beyond the preview
Go deeper on Tumor Site-Specific DNA Damage (None).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tumor Site-Specific DNA Damage (None).